Ramchandra K. Ranvir

Ahmedabad, UP, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Pair-Feeding Differentiates Feed-Dependent and Pharmacodynamic Effects of Telmisartan in Wistar Rats.

Pair-Feeding Differentiates Feed-Dependent and Pharmacodynamic Effects of Telmisartan in Wistar Rats.

Journal: International journal of toxicology
Published: February 27, 2026

Case Report: Post-stroke hemorrhagic infarction in a status epilepticus Beagle dog.

Case Report: Post-stroke hemorrhagic infarction in a status epilepticus Beagle dog.

Journal: Frontiers in veterinary science
Published: December 10, 2025

Juvenile toxicity and developmental safety of Zintrodiazine, a novel antimalarial candidate, in Wistar rats.

Juvenile toxicity and developmental safety of Zintrodiazine, a novel antimalarial candidate, in Wistar rats.

Journal: The Journal of antimicrobial chemotherapy
Published: October 07, 2025

Integrating immune adverse outcome pathways into vaccine safety evaluation.

Integrating immune adverse outcome pathways into vaccine safety evaluation.

Journal: Archives of toxicology
Published: August 31, 2025

A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats.

A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats.

Journal: International journal of toxicology
Published: August 30, 2025

Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats.

Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats.

Journal: Chemico-biological interactions
Published: August 29, 2025

Usnoflast: A cutting-edge NLRP3 inhibitor attenuates colonic inflammation across diverse immunopathology.

Usnoflast: A cutting-edge NLRP3 inhibitor attenuates colonic inflammation across diverse immunopathology.

Journal: European journal of pharmacology
Published: April 16, 2025

Preclinical safety, tolerability and pharmacokinetics of a novel cyclobenzaprine hydrochloride nasal spray.

Preclinical safety, tolerability and pharmacokinetics of a novel cyclobenzaprine hydrochloride nasal spray.

Journal: Regulatory toxicology and pharmacology : RTP
Published: February 06, 2025

Safety Assessment of a Novel Intravenous Diclofenac Sodium Formulation Following 28-Day Repeated Administration in Wistar Rats.

Safety Assessment of a Novel Intravenous Diclofenac Sodium Formulation Following 28-Day Repeated Administration in Wistar Rats.

Journal: International journal of toxicology
Published: June 20, 2024

A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's disease.

A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's disease.

Journal: Brain research
Published: January 27, 2024

Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.

Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.

Journal: BMC cancer
Published: July 05, 2022

Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.

Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.

Journal: Bioorganic & medicinal chemistry
Published: December 07, 2020
Showing 1-12 of 20

Last Updated: 09/26/2026